Evidence map›Paper›PMID 33185461›Full record

ArticleCirculation2021

Oxidation of Protein Kinase A Regulatory Subunit PKARIα Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Lysosomal-Triggered Calcium Release.

Jillian N Simon, Besarte Vrellaku, Stefania Monterisi, Sandy M Chu, Nadiia Rawlings, Oliver Lomas, Gerard A Marchal, Dominic Waithe, Fahima Syeda, Parag R Gajendragadkar and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Circulation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Lysosomal CaCirculation. Arrhythmia and electrophysiology · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Mitochondrial Kinase Signaling for Cardioprotection.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Lysosomal CaPNAS nexus · 2023
    Article
  16. Lysosomal CaCell death discovery · 2023
    Article
  17. Article
  18. NAADP-Mediated CaHandbook of experimental pharmacology · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 2 countries.

Jillian N SimonDivision of Cardiovascular Medicine, Radcliffe Department of Medicine (J.N.S., B.V., S.M.C., N.R., O.L., G.A.M., P.R.G., R.J., K.M.C., B.C.), University of Oxford, United Kingdom.
Besarte VrellakuDivision of Cardiovascular Medicine, Radcliffe Department of Medicine (J.N.S., B.V., S.M.C., N.R., O.L., G.A.M., P.R.G., R.J., K.M.C., B.C.), University of Oxford, United Kingdom.
Stefania MonterisiDepartment of Physiology, Anatomy and Genetics (S.M., P.S., M.Z.), University of Oxford, United Kingdom.
Sandy M ChuDivision of Cardiovascular Medicine, Radcliffe Department of Medicine (J.N.S., B.V., S.M.C., N.R., O.L., G.A.M., P.R.G., R.J., K.M.C., B.C.), University of Oxford, United Kingdom.
Nadiia RawlingsDivision of Cardiovascular Medicine, Radcliffe Department of Medicine (J.N.S., B.V., S.M.C., N.R., O.L., G.A.M., P.R.G., R.J., K.M.C., B.C.), University of Oxford, United Kingdom.
Oliver LomasDivision of Cardiovascular Medicine, Radcliffe Department of Medicine (J.N.S., B.V., S.M.C., N.R., O.L., G.A.M., P.R.G., R.J., K.M.C., B.C.), University of Oxford, United Kingdom.
Gerard A MarchalDivision of Cardiovascular Medicine, Radcliffe Department of Medicine (J.N.S., B.V., S.M.C., N.R., O.L., G.A.M., P.R.G., R.J., K.M.C., B.C.), University of Oxford, United Kingdom.
Dominic WaitheWolfson Imaging Centre, Weatherall Institute of Molecular Medicine (D.W.), University of Oxford, United Kingdom.
Fahima SyedaInstitute of Cardiovascular Sciences, University of Birmingham, United Kingdom (F.S., L.F.).
Parag R GajendragadkarDivision of Cardiovascular Medicine, Radcliffe Department of Medicine (J.N.S., B.V., S.M.C., N.R., O.L., G.A.M., P.R.G., R.J., K.M.C., B.C.), University of Oxford, United Kingdom.
Raja JayaramDivision of Cardiovascular Medicine, Radcliffe Department of Medicine (J.N.S., B.V., S.M.C., N.R., O.L., G.A.M., P.R.G., R.J., K.M.C., B.C.), University of Oxford, United Kingdom.
Rana SayeedCardiothoracic Surgery, Oxford Heart Centre, Oxford University Hospitals National Health Service Foundation Trust, United Kingdom (R.S.).
Keith M ChannonDivision of Cardiovascular Medicine, Radcliffe Department of Medicine (J.N.S., B.V., S.M.C., N.R., O.L., G.A.M., P.R.G., R.J., K.M.C., B.C.), University of Oxford, United Kingdom.
Larissa FabritzInstitute of Cardiovascular Sciences, University of Birmingham, United Kingdom (F.S., L.F.).
Pawel SwietachDepartment of Physiology, Anatomy and Genetics (S.M., P.S., M.Z.), University of Oxford, United Kingdom.
Manuela ZaccoloDepartment of Physiology, Anatomy and Genetics (S.M., P.S., M.Z.), University of Oxford, United Kingdom.
Philip EatonWilliam Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, United Kingdom (P.E.).
Barbara CasadeiDivision of Cardiovascular Medicine, Radcliffe Department of Medicine (J.N.S., B.V., S.M.C., N.R., O.L., G.A.M., P.R.G., R.J., K.M.C., B.C.), University of Oxford, United Kingdom.
John Radcliffe Hospital · GBUniversity of Oxford · GBBritish Heart Foundation · GBMansfield University · USMRC Weatherall Institute of Molecular Medicine · GBNIHR Surgical Reconstruction and Microbiology Research Centre · GBRCA (United States) · USUniversity of Birmingham · GBWilliam Harvey Research Institute · GB

Funding

British Heart Foundation AA/18/2/34218British Heart Foundation CH/12/3/29609British Heart Foundation CH/16/1/32013British Heart Foundation FS/17/17/32438British Heart Foundation PG/10/75/28537British Heart Foundation PG/15/5/31110British Heart Foundation PG/16/66/32288British Heart Foundation PG/17/44/33064British Heart Foundation PG/19/33/34385British Heart Foundation RG/07/003/23133British Heart Foundation RG/11/15/29375British Heart Foundation RG/12/3/29423British Heart Foundation RG/12/5/29576British Heart Foundation RG/15/9/31534British Heart Foundation RG/16/12/32451British Heart Foundation RG/17/10/32859British Heart Foundation RG/17/16/33294British Heart Foundation RG/17/6/32944Medical Research Council G0700320Medical Research Council MR/K01577X/1Medical Research Council MR/P023150/1Medical Research Council MR/P023150/2Medical Research Council MR/R01065X/1Medical Research Council MR/R01065X/2Medical Research Council MR/S005382/1Wellcome Trust 0998981Z/12/Z
6 · The paper itself

Abstract

backgroundKinase oxidation is a critical signaling mechanism through which changes in the intracellular redox state alter cardiac function. In the myocardium, PKARIα (type-1 protein kinase A) can be reversibly oxidized, forming interprotein disulfide bonds in the holoenzyme complex. However, the effect of PKARIα disulfide formation on downstream signaling in the heart, particularly under states of oxidative stress such as ischemia and reperfusion (I/R), remains unexplored.

methodsAtrial tissue obtained from patients before and after cardiopulmonary bypass and reperfusion and left ventricular (LV) tissue from mice subjected to I/R or sham surgery were used to assess PKARIα disulfide formation by immunoblot. To determine the effect of disulfide formation on PKARIα catalytic activity and subcellular localization, live-cell fluorescence imaging and stimulated emission depletion super-resolution microscopy were performed in

resultsIn both humans and mice, myocardial PKARIα disulfide formation was found to be significantly increased (2-fold in humans,

conclusionsDisulfide modification targets PKARIα to the lysosome, where it acts as a gatekeeper for two-pore channel-mediated triggering of global calcium release. In the postischemic heart, this regulatory mechanism is critical for protection from extensive injury and offers a novel target for the design of cardioprotective therapeutics.

Indexed as

AnimalsCalciumCyclic AMP-Dependent Protein Kinase RIalpha SubunitCyclic AMP-Dependent Protein KinasesHumansMiceMyocardial Reperfusion InjuryOxidation-ReductionCalciumCyclic AMP-Dependent Protein Kinase RIalpha SubunitCyclic AMP-Dependent Protein Kinasescalcium signalinglysosomeprotein kinase A phosphorylationredoxreperfusion injury

Identifiers

PMID33185461
PMCPMC7846288
OpenAlexW3100037683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.